Dnp Therapeutics Inc

CIK 2122106 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Dnp Therapeutics Inc.

Recent SEC filings

FiledFormAccession number
Mar 23, 2026D0002122106-26-000001